...
首页> 外文期刊>Allergology international: official journal of the Japanese Society of Allergology >The Asthma Control Test, Japanese Version (ACT-J) as a Predictor of Global Initiative for Asthma (GINA) Guideline-Defined Asthma Control: Analysis of a Questionnaire-Based Survey
【24h】

The Asthma Control Test, Japanese Version (ACT-J) as a Predictor of Global Initiative for Asthma (GINA) Guideline-Defined Asthma Control: Analysis of a Questionnaire-Based Survey

机译:哮喘控制测试,日语版(ACT-J),作为全球哮喘倡议(GINA)指南中定义的哮喘控制的预测指标:基于问卷调查的分析

获取原文
           

摘要

ABSTRACT Background The 2006 Global Initiative for Asthma (GINA 2006) guidelines emphasize the importance of evaluating the control rather than the severity of asthma. The Asthma Control Test (ACT) is well known to be an excellent tool for evaluating asthma control in the clinical setting. This study aimed to evaluate the ACT, Japanese version (ACT-J) as a predictor of asthma control as defined by the GINA 2006 guidelines in actual clinical practice. Methods A cross-sectional analysis comparing the ACT-J score and GINA classification of asthma control among 419 patients of primary care physicians and specialists was performed using the data from a 2010 questionnaire-based survey conducted by the Niigata Asthma Treatment Study Group. Results The optimal cut-off point of the ACT-J score for predicting GINA-defined asthma control was 23, with ACT-J scores of ≥ 23 and ≤ 22 predicting controlled and uncontrolled asthma with area under the receiver operating characteristics curve values of 0.76 [95% confidence interval (CI): 0.72-0.81] and 0.93 [95% CI: 0.900.97], respectively. Conclusions ACT scores of ≥ 23 and ≤ 22 are useful for identifying patients with controlled and uncontrolled asthma, respectively, as defined by GINA 2006, and the latter is more strongly predictive than the former. The reason for the higher cut-off point of the ACT-J relative to other versions of the ACT is unclear and warrants further investigation.
机译:摘要背景2006年全球哮喘防治倡议(GINA 2006)指南强调评估控制的重要性而不是哮喘的严重性。众所周知,哮喘控制测试(ACT)是评估临床环境中哮喘控制的出色工具。这项研究旨在评估ACT(日本版)(ACT-J)作为GINA 2006指南在实际临床实践中定义的哮喘控制预测指标。方法使用新泻市哮喘治疗研究小组基于2010年问卷调查的数据,对419名初级保健医师和专科患者的ACT-J得分和GINA分类进行哮喘控制进行横断面分析。结果用于预测GINA定义的哮喘控制的ACT-J评分的最佳分界点是23,其中ACT-J评分≥23和≤22预测控制性和非控制性哮喘,且受试者工作特征曲线值下的面积为0.76 [95%置信区间(CI):0.72-0.81]和0.93 [95%CI:0.900.97]。结论根据GINA 2006的定义,ACT得分≥23和≤22可分别用于识别控制性哮喘和非控制性哮喘患者,后者比前者具有更强的预测能力。 ACT-J相对于其他版本的ACT更高的截止点的原因尚不清楚,因此有待进一步研究。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号